CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED) (USD $) In Millions, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
EARNINGS
Net Sales	$ 5,345	$ 4,798	$ 15,790	$ 14,373
Cost of products sold	1,407	1,280	4,231	3,863
Marketing, selling and administrative	1,019	892	2,987	2,686
Advertising and product promotion	205	231	672	706
Research and development	973	824	2,831	2,556
Provision for restructuring	8	15	92	50
Litigation expense, net		22		22
Equity in net income of affiliates	(71)	(70)	(215)	(252)
Other (income)/expense	(26)	(10)	(195)	84
Total Expenses	3,515	3,184	10,403	9,715
Earnings Before Income Taxes	1,830	1,614	5,387	4,658
Provision for income taxes	475	312	1,358	987
Net Earnings	1,355	1,302	4,029	3,671
Net Earnings Attributable to Noncontrolling Interest	386	353	1,172	1,052
Net Earnings Attributable to Bristol-Myers Squibb Company	$ 969	$ 949	$ 2,857	$ 2,619
Earnings per Common Share Attributable to Bristol-Myers Squibb Company:
Basic	$ 0.57	$ 0.55	$ 1.67	$ 1.52
Diluted	$ 0.56	$ 0.55	$ 1.66	$ 1.51
Dividends declared per common share	$ 0.33	$ 0.32	$ 0.99	$ 0.96